Russo, I. et al. 2022. Omalizumab for the treatment of chronic spontaneous urticaria: association between body mass index and outcome. Dermatology Practical & Conceptual. 12, 4 (Oct. 2022), e2022148. DOI:https://doi.org/10.5826/dpc.1204a148.